Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Dear Friend;Dr. George Adams 👀Visionary with Ventripoint🚀
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(14)
•••
Comment by jopatcloon Oct 31, 2024 11:49am
26 Views
Post# 36290696

RE:RE:RE:Dear Friend;Dr. George Adams 👀Visionary with Ventripoint🚀

RE:RE:RE:Dear Friend;Dr. George Adams đź‘€Visionary with Ventripoint🚀Interesting see post on Linkedin  Celebrating 10 years of the Philips Foundation : a decade of making waves in healthcare.
& I think Dr. Adams is a visionary with Ventripoint for the health of children and now also for all.
Celebrating 10 years of the Philips Foundation : a decade of making waves in healthcare. One step at a time, we’re transforming access to life-saving care around the world.

I’m proud of the Foundation’s vital work in fighting rheumatic heart disease (RHD), which affects many young people worldwide. For example, in a recent partnership with heart Healers International and the World Heart Federation, they’ve screened over 100,000 children in Uganda and the Philippines using handheld ultrasound devices, making a real difference.

It’s inspiring to be part of a company committed to improving health outcomes in vulnerable communities. Watch the video to hear from Dr. Craig Sable on how AI is advancing RHD diagnosis and patient care.

RheumaticHeartDisease HealthForAll DecadeOfImpact
 
Loaded: 100.00%
 
 
Remaining time 0:03
 
 
How Philips Foundation is Fighting Rheumatic Heart Disease

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities